RNS System Webinar | Focal Epilepsy Treatment

Skip to main content
NeuroPace, Inc
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search
Could the RNS System be right for me? Start Quiz

Educational Webinar

Is Long Term Seizure Reduction Possible?

Advanced Treatments for Focal Epilepsy Including the RNS® System

Register Here

Learn more about the RNS System and results from a landmark clinical study

Rapid Seizure Reduction

62%

Median seizure reduction at 6 months1

n=292

Long-Term Seizure Reduction

82%

Median seizure reduction at 3 years1

n=255

Seizure-Free Periods Achieved

42%

Of patients seizure free for 6+ months1,2

n=268

SUDEP Reduction

3x

Lower rate of SUDEP vs ASM placebo3

  1. RNS System Post-approval Study Oral Presentation, American Academy of Neurology, April 2025, all outcomes are ITT, median seizure reduction is observed case data
  2. At some point during the study
  3. Compared to placebo arm of ASM trial. 2.3/1000 patient years rate of SUDEP in RNS System prospective studies vs 6.9/1000 patient years rate of SUDEP in Anti-seizure Medication (ASM) placebo; Ryvlin et al, Lancet Neurol, 2011

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci. See important prescribing and safety information at www.NeuroPace.com/safety. Refer to the labeling for a description of the RNS® System and its components, indications for use, contraindications, warnings, cautions, adverse events and instructions for use.

Dr. Amir Faraji

Featuring

Dr. Amir Faraji

Dr. Amir Faraji is the Director of Functional Neurosurgery and a board-certified neurosurgeon in Houston, Texas at the Houston Methodist Hospital. He received his medical and doctorate degrees from the University of Pittsburgh and a fellowship in stereotactic and functional neurosurgery and epilepsy surgery at the University of Pittsburgh Medical Center. He also completed a second fellowship in peripheral nerve surgery at the Washington University in St. Louis and Barnes-Jewish Hospital. Dr. Faraji specializes in epilepsy surgery, peripheral nerve surgery, and stereotactic & functional neurosurgery and is experienced in neuromodulation (deep brain stimulation), brain tumor surgery, peripheral nerve disorders, radiosurgery, MR-guided focused ultrasound, and gene and cell therapy.

Dr. Faraji is also a scientist at the Clinical Innovations Laboratory at the Houston Methodist Research Institute. He is involved in numerous clinical trials in neuroregeneration and neuromodulation.

Register Here






Are you currently receiving care at any of these hospitals? (Optional)
Is your loved one currently receiving care at any of these hospitals? (Optional)
What best describes your situation?
What best describes your loved one's situation?
An epilepsy specialist, or epileptologist, is a neurologist who specializes in caring for people with epilepsy. They have completed an additional one or two years of subspecialty training in epilepsy care.
An epilepsy specialist, or epileptologist, is a neurologist who specializes in caring for people with epilepsy. They have completed an additional one or two years of subspecialty training in epilepsy care.
By submitting this form, I give permission for NeuroPace to contact me via phone, email, or text message from time to time including regular informational emails. I understand that I can opt out of one or all communication methods at any time. NeuroPace will never sell my data or personal information, and I agree to the company's privacy policy.













reCAPTCHA helps prevent automated form spam.
The submit button will be disabled until you complete the CAPTCHA.


Thank you for registering.
  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

CORPORATE

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure

  • PATIENTS

    Safety

  • PROVIDERS

    Legal

  • INVESTORS

    Privacy Policy

  • CORPORATE

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc.

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.

  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials